Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — UK Government Report Says Drug Enforcement Triggers Increases in Violence

A government-commissioned report in the UK has found that efforts to crack down on drug activity through law enforcement are more likely to drive up violence rather than decrease it. While it’s unclear whether this will push the government to change course on drug policy, the findings are significant.

According to the report, existing evidence shows that drug-related policing does little to cut violence. In fact, many studies show the opposite—that such enforcement efforts often make things worse. The research also revisits earlier work on the topic, which concluded that stepping up police pressure on drug markets usually fails to curb violence and might increase it.

The report advises law enforcement agencies in the UK to weigh the potential for violence before launching operations focused on drugs, especially when these actions involve arresting key figures in drug networks or seizing large amounts of substances. These actions, while intended to disrupt illegal trade, often create instability and spark turf wars among criminal groups.

According to Transform Drug Policy Foundation senior analyst Steve Rolles, the unintended consequences of drug enforcement have been evident for years. He contends that the “war on drugs” has exacerbated the ongoing conflict between criminal organizations and law enforcement, making it possible for only the most vicious gangs to endure.

Rolles sees the report as an important moment, mainly because it comes from the Home Office. The office is responsible for issues such as policing and national security.

Many former law enforcement officers have also spoken out over the years about how drug enforcement can increase street violence. They point out that when established hierarchies in the drug trade are disrupted—through arrests or seizures—power vacuums form, sparking violent competition among rival groups.

Neil Woods, once an undercover cop, is now a leading advocate for changing drug laws. He chairs the Law Enforcement Action Partnership UK and argues that traditional drug policing doesn’t shrink the drug market. Instead, it often makes things more dangerous. He believes the findings of the report should influence government policy as public safety is at stake.

Woods also notes that cracking down on drug suppliers can increase overdose risks. A 2023 study published in the American Journal of Public Health showed that when a person’s dealer is arrested, they may turn to unfamiliar sources, increasing the chance of encountering contaminated or more potent drugs.

These findings are unlikely to surprise licensed marijuana companies like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) given that they have always believed that marijuana policy reform is a more sustainable way to reduce drug-related violence in different jurisdictions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Largest-Ever Research Finds Medical Marijuana Could Help Combat Cancer

A recent study—the largest of its kind—has found strong scientific backing for the use of medical marijuana in managing cancer symptoms and possibly even affecting how the disease progresses. Published in Frontiers in Oncology, the research pulls together a vast amount of existing evidence to assess where science stands on the topic.

Ryan Castle, who leads research at the Whole Health Oncology Institute, spearheaded the analysis. According to him, the aim was to cut through years of conflicting studies and unclear messaging. A big challenge, Castle explained, is that marijuana is still categorized as a Schedule I drug at the federal level, which makes high-quality clinical research in the U.S. difficult to conduct.

The study was backed by Cancer Playbook, a group that works alongside the Whole Health Oncology Institute to gather and analyze patient feedback on treatments. Even though legal barriers limit formal trials on marijuana, there’s a huge volume of observational research and lab-based studies that look at how marijuana affects cancer—both in terms of symptom relief and its impact on cancer cells.

Castle’s team reviewed over 10,000 studies, far exceeding the scope of any previous analysis on this subject. To handle the massive dataset, they used artificial intelligence—specifically, a technique called sentiment analysis—to sort the findings. This allowed them to gauge how many studies supported marijuana, how many were neutral, and how many were negative. They looked at effects like reducing inflammation, improving appetite, and promoting cancer cell death, known as apoptosis.

Around 75% of the studies suggested that marijuana had a positive impact on cancer symptoms, and in many cases, also indicated it might help stop the disease from spreading.

Despite promising signs, there’s still debate. A 2024 JAMA study suggested a higher risk of neck and head cancers among those with marijuana-use disorder, but some critics, like UCSF oncologist Dr. Donald Abrams, argue that the study overlooked key risk factors like alcohol and tobacco use.

Abrams, who’s been treating cancer patients for over four decades, supports using marijuana to manage symptoms but is less convinced about its ability to treat cancer directly. Still, he acknowledges that lab studies have shown marijuana can impact tumors in animals and test tubes, though those results haven’t yet been mirrored in large-scale trials on humans.

Castle remains optimistic. He points to smaller human studies showing extended survival times or reduced tumor sizes in patients who received marijuana-based treatments alongside chemotherapy. However, he emphasizes that more robust human trials are essential.

Ultimately, Castle hopes the findings will help push U.S. regulators to reclassify marijuana, removing roadblocks to further clinical research.

The easing of existing barriers to research could allow products from licensed companies like SNDL Inc. (NASDAQ: SNDL) to be extensively analyzed for their therapeutic potential.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Most People in Canada Support Expanding the Marijuana Industry, Survey Finds

Most Canadians believe the government should do more to support the legal marijuana industry, according to a recent national poll. The survey, conducted by Abacus Data for Organigram Global, found that 64% of adults in Canada think the government should make it easier for the marijuana sector to expand. This view spans all regions and age groups.

Support was especially strong in Atlantic Canada, where 65% backed more government action. Similar levels of support were seen in British Columbia (61 percent), Ontario (62 percent), and the Prairies (64 percent). Even among citizens over 60—a group often more skeptical of cannabis—57% agreed that the industry deserves greater backing.

These results come at a time when Canada is heading into a federal election and facing economic uncertainty, particularly in light of strained trade relations with the United States. The marijuana sector, despite being relatively new, is becoming a significant player in the national economy. Last year, it added $7.4 billion to the nation’s GDP, outpacing sectors like forestry and brewing, which contributed $3.3 billion and $2.6 billion, respectively.

Beena Goldenberg, the CEO of Organigram, noted that Canadians want the government to help homegrown industries thrive, and marijuana is one of them. She emphasized that the incoming prime minister should focus on removing barriers that are holding the sector back.

Nearly 90% of respondents also said they believe Canada needs to explore new avenues for economic growth. A similar number agreed that the country should act quickly to capitalize on fresh opportunities in emerging industries.

Since cannabis was legalized in 2018, the sector has generated over $43 billion in GDP and now supports more than 80,000 jobs, according to figures cited from Deloitte.

The survey, conducted from April 3 to April 8, surveyed 1,915 adults in Canada. It has a margin of error of plus or minus 2.24%.

The analysis also outlined specific steps the government could take—such as simplifying taxes, easing interprovincial sales restrictions, and encouraging research and development. It suggested that targeted support could especially help regions hit hard by declines in traditional sectors.

While the rollout of marijuana legalization wasn’t perfect, most indicators point to a positive outcome. Previous surveys show Canadians are largely purchasing cannabis through legal channels now, and youth usage hasn’t spiked—countering fears raised by critics of legalization. A government report from December last year revealed that only 3% of consumers still turn to illegal sources.

If these sentiments are acted upon and the cannabis program is expanded, there could be room for entrepreneurs to start firms similar to Innovative Industrial Properties Inc. (NYSE: IIPR) that serve marijuana companies and create a lot more benefits through their operations.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Makers of THC-Infused Drinks Seek Adults to Participate in Observational Study

A group of cannabis beverage companies is launching a large-scale research project focused on how THC-infused drinks might affect alcohol use, mood, and overall well-being. The study is open to up to 2,000 adults who will receive complimentary marijuana beverages to use during the research period.

Other industry firms like Curaleaf Holdings Inc. (CBoe CA: CURA) (OTCQX: CURLF) will keep an eye on this study and…

420 with CNW — Delaware Lawmakers Consider Bills to Address Gaps in Marijuana Law

Two measures designed to speed up Delaware’s launch of its recreational cannabis market are currently under review in the state legislature. These legislative efforts come after delays have stalled the rollout of cannabis retail operations, despite business licenses being awarded last year.

Originally, the state had planned to open its recreational cannabis market this month. However, that timeline has been thrown off due to legal issues with the Marijuana Control Act—the law outlining the industry’s regulatory process. One of the main roadblocks is a delay in obtaining approval from the FBI to implement a fingerprint-based background check system, a requirement before the state can officially issue licenses.

Delaware’s regulators have already submitted two requests to the FBI, both of which were rejected. The problem lies in how the state’s law outlines applicant background checks—it needed to be adjusted to meet federal standards. Changes to address that were introduced earlier this month and passed the House. The goal is to get the legislation through both chambers quickly so the state can try again with the FBI.

The proposal is now before the Senate Executive Committee and will head to the full Senate for a vote. If approved and signed into law, the Marijuana Commissioner’s Office will be able to restart the process of conducting background checks and issuing conditional licenses to the 125 approved operators.

Even with licenses in hand, many businesses are struggling to find store locations. Strict zoning laws in the state’s three counties have created major obstacles. Around one-third of the state’s municipalities have completely banned cannabis retailers, and many others have made it very difficult to find compliant locations due to zoning buffers.

To address this, a second measure, SB 75, proposes loosening those zoning restrictions. The bill aims to standardize the minimum distance between cannabis stores and places like schools, treatment centers, and daycares to 500 feet. It also removes worship places from the list of protected areas.

Sussex County currently enforces a three-mile buffer, while New Castle sets a 1,000-foot limit between dispensaries and certain locations.

The measure also supports existing medical dispensaries—known as compassion centers—by allowing them to convert to recreational use and make necessary building changes. It also guarantees that indoor grow facilities can operate in industrial and agricultural zones and sets standard hours of operation for cannabis businesses.

While there was pushback from some GOP senators, especially over removing churches from the protected category and concerns about undermining local control, the bill passed the Senate with a 13-8 vote. It now moves to a House committee before heading to the floor for a final decision.

The broader marijuana industry, including entities like Green Thumb Industries Inc. (Cboe CA: GTII) (OTCQX: GTBIF) will be hoping that these pieces of legislation finally get the market launch back on track in Delaware.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — What You Need to Know About the 420 Cannabis Holiday

This year, an unusual overlap is happening: Easter Sunday and the unofficial cannabis celebration known as 420 both land on April 20. It’s a rare coincidence that hasn’t occurred in more than a decade. While Easter is a sacred day for Christians, marking the resurrection of Jesus, 420 is widely recognized by cannabis users as a day to celebrate marijuana culture.

So, what exactly is 420, and where did it come from? While the exact origins remain debated, the term has become a global symbol of cannabis use.

In places where marijuana is legal, people mark the day with festivals, film screenings, educational events, and other gatherings focused on cannabis. Dispensaries and smoke shops typically run promotions and discounts, taking advantage of the day’s popularity.

Even in areas where cannabis remains illegal federally, April 20 is often used as a day for activism, pushing for legalization and policy reform.

According to reports, the connection between cannabis and 420 dates back to the early 1970s and a group of youngsters from San Rafael High School in Northern California. They dubbed themselves “the Waldos” and had a routine of getting together to smoke pot at 4:20 p.m. after school.

One of the group members, Steve Capper, emphasized they weren’t just goofing off—they were solid students with good records. The chosen meeting time, 4:20, became a kind of inside joke and secret code for getting high.

Eventually, this code spread. One of the Waldos, Dave Reddix, ended up working with the Grateful Dead, a band deeply tied to 1970s counterculture. Through their fan base, known as Deadheads, the term 420 gained traction.

A flyer circulated at a 1990 concert in Oakland invited attendees to smoke weed on April 20 at 4:20 p.m. That flyer reached journalist Steven Bloom, who later published it in High Times magazine. From there, the term exploded in popularity and became permanently linked with cannabis culture.

Other theories float around—some say 420 is a police radio code or that it’s tied to lyrics from Bob Dylan. But the original Waldos stand by their story and have long claimed credit for the term’s rise.

This year’s double observance of Easter and 420 won’t happen again until 2087, making this overlap especially noteworthy. For many, it’s a day of spiritual reflection; for others, a time to come together over a shared love of cannabis.

Either way, April 20 carries meaning for millions and firms like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) will look back on how far they have come and leverage this holiday as they seek to take their operations to the next level.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — What You Need to Know About the 420 Cannabis Holiday

Either way, April 20 carries meaning for millions and firms like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) will look back on how far they have…

420 with CNW — How U.S. Marijuana Companies Are Responding to President Trump’s Tariffs

Marijuana firms and related businesses are adjusting quickly to changing U.S. trade policies, particularly under the tariff strategies introduced by the Trump administration. Many of these businesses rely heavily on global suppliers, especially for packaging and manufacturing, and the tariffs have added new pressure to an already complex supply chain.

It remains to be seen what innovations marijuana firms like Cresco Labs Inc. (OTCQX: CRLBF) (CNX: CL) (FRA: 6CQ) will introduce to cope with the…

420 with CNW — How U.S. Marijuana Companies Are Responding to President Trump’s Tariffs

Although there have been efforts to boost U.S. manufacturing, the cannabis industry isn’t yet equipped to meet growing demand domestically. Packaging, for instance, often requires specialized technology that’s still lacking in the U.S., making overseas production necessary.

Some companies are taking steps to move parts of their operations back home. Custom Cones USA, for example, shifted its production of plastic pre-roll tubes to the U.S. to cut down on long shipping times and reduce warehousing needs. Still, the bulk of their key products are made in countries like India, Indonesia, and China. The sharp increase in tariffs, including a recent 145% hike on certain Chinese goods, has made importing even more expensive.

Despite efforts to relocate some production, there are limitations. U.S. facilities often can’t match Chinese manufacturers’ flexibility or low costs, especially for custom or small-batch orders. As a result, industry leaders say higher prices on consumer products like pre-rolls may be unavoidable if tariffs remain.

Ispire Technology, a marijuana-focused offshoot of Aspire, has already started shifting manufacturing from China to countries such as Malaysia, hoping to offset rising costs. The company is also leaning into pod-based vape systems, which reduce recurring hardware expenses and the tariff burden on components.

Meanwhile, some businesses are setting up new distribution channels. Custom Cones, for example, plans to ship directly to Canada from its Indonesian plant to maintain its supply chain amid growing trade tension between Canada and the U.S.

On the logistics side, companies such as Talaria are working to manage rising operational costs by automating warehouses, optimizing delivery routes, and partnering with more U.S.-based suppliers. But they, too, face uncertainty, especially with vehicle imports subject to future tariff changes.

Other businesses, like ZZZ’s Collective, are sticking with international suppliers despite shrinking profit margins, prioritizing consistency and customer trust over short-term savings.

Many in the industry warn that if economic conditions worsen or tariffs stay high, consumers will eventually see higher prices. Some worry that higher prices and taxes could drive buyers back to the black market, undermining efforts to build a legal, stable cannabis industry.

It remains to be seen what innovations marijuana firms like Cresco Labs Inc. (OTCQX: CRLBF) (CNX: CL) (FRA: 6CQ) will introduce to cope with the increasingly challenging business environment in light of the trade war.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Research Shows Marijuana Extract Improves Behavior of Autistic Kids, Teens

New findings shared at the 2025 European Congress of Psychiatry suggest that cannabidiol (CBD), a compound found in marijuana, may offer behavioral benefits for teens and children with autism spectrum disorder (ASD).

ASD affects roughly one in a hundred children globally. It often involves challenges with communication, emotional expression, social interactions, and a tendency toward repetitive behaviors. In the U.S., diagnoses have surged by roughly 175% from 2011 to 2022, with the latest data from the CDC estimating that 1 in 36 American children are on the spectrum.

Many of these children face behavioral and emotional challenges that go beyond those typically seen in neurotypical youth, often placing a heavy burden on families and caregivers.

Dr. Lara Branco, the lead author of the study, noted that although more adolescents and children are being diagnosed with ASD, treatment options remain limited and are often ineffective.

CBD is a major component of cannabis but does not cause a high like THC. Scientists suggest it interacts with receptors in the body and brain to potentially deliver therapeutic effects without intoxication.

The recent study explored data from three placebo-controlled clinical trials focused on adolescents and children with ASD. It involved a total of 276 youngsters aged 5 to 21 (average age of 10.5 years). About 78 percent of the participants were male. CBD was administered at an initial dose of 1 mg per kilogram of body weight per day, gradually increased to as much as 10 mg/kg.

The research showed that CBD extract led to reduced problem behaviors, lowered anxiety, better sleep, and improvements in social interaction. Notably, these benefits came without an increased risk of side effects. The effects were similar between those taking CBD and those given a placebo, suggesting it is generally safe for use in this group.

European Psychiatric Association President Professor Geert Dom welcomed the results, noting the frustration many families and doctors feel due to the lack of effective therapies for ASD. He expressed hope that findings like these could spark more research and eventually lead to better treatment strategies for the autism community.

Despite the promising results, the researchers pointed out that their analysis had some limitations, including a limited number of trial studies and relatively few participants. They noted that larger, high-quality trial studies are still needed to fully understand the long-term safety and effectiveness of CBD in treating autism symptoms.

Such studies are helping to provide further proof of the therapeutic potential of medical marijuana products from enterprises like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) and other industry actors as research documents how various cannabis compounds can help in addressing different symptoms.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com